A Detailed Analysis of Alcohol Pharmacokinetics in Healthy Korean Men
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
To determine blood alcohol concentration (BAC) by extrapolation, an understanding of basal pharmacokinetics is indispensable. Breath alcohol concentration (BrAC) has been used for the determination of body alcohol concentration replaced by BAC in Korea. Therefore, the determination of BAC/BrAC ratio is a key problem in alcohol pharmacokinetics. Among several factors, the ingested dose of alcohol and the allelic variation of mitochondrial aldehyde dehydrogenase 2 (ALDH2) are the most significant factors influencing the pharmacokinetic parameters, particularly in the absorption and elimination phases. This study shows a detailed pharmacokinetic analysis of BAC and BrAC associated with genetic polymorphism including ALDH2 in 42 healthy Korean men. The change in the alcohol dose ingested influenced the maximum concentration (Cmax), the time to reach Cmax (Tmax), the absorption rate constant (K01), the area under the concentration-time curve (AUClast), and the hourly elimination rate. The conversion of wild-type 487Glu (ALDH2*1) to 487Lys (ALDH2*2) in human ALDH2 resulted in changes in Cmax (ALDH2*1/*1, 0.03±0.01 g/dL [±standard deviation] vs. ALDH2*1/*2, 0.05±0.004 g/dL [P<0.01]), AUClast (ALDH2*1/*1, 4.48±2.19 g∙min/dL vs. ALDH2*1/*2, 7.52±1.26 g∙min/dL [P<0.05]), and the BAC elimination rate (ALDH2*1/*1, 0.05±0.02 g/L/hr vs. ALDH2*1/*2, 0.09±0.01 g/L/hr [P<0.05]). Moreover, the comparison of BAC and BrAC by Bland-Altman plot showed good agreement, suggesting that the measurement of BrAC can be a good alternative for the determination of BAC, particularly in the post-absorption phase. These results provide fundamental information about the pharmacokinetics of alcohol and the determination of BAC in forensics.
Abstract
To determine blood alcohol concentration (BAC) by extrapolation, an understanding of basal pharmacokinetics is indispensable. Breath alcohol concentration (BrAC) has been used for the determination of body alcohol concentration replaced by BAC in Korea. Therefore, the determination of BAC/BrAC ratio is a key problem in alcohol pharmacokinetics. Among several factors, the ingested dose of alcohol and the allelic variation of mitochondrial aldehyde dehydrogenase 2 (ALDH2) are the most significant factors influencing the pharmacokinetic parameters, particularly in the absorption and elimination phases. This study shows a detailed pharmacokinetic analysis of BAC and BrAC associated with genetic polymorphism including ALDH2 in 42 healthy Korean men. The change in the alcohol dose ingested influenced the maximum concentration (Cmax), the time to reach Cmax (Tmax), the absorption rate constant (K01), the area under the concentration-time curve (AUClast), and the hourly elimination rate. The conversion of wild-type 487Glu (ALDH2*1) to 487Lys (ALDH2*2) in human ALDH2 resulted in changes in Cmax (ALDH2*1/*1, 0.03±0.01 g/dL [±standard deviation] vs. ALDH2*1/*2, 0.05±0.004 g/dL [P<0.01]), AUClast (ALDH2*1/*1, 4.48±2.19 g∙min/dL vs. ALDH2*1/*2, 7.52±1.26 g∙min/dL [P<0.05]), and the BAC elimination rate (ALDH2*1/*1, 0.05±0.02 g/L/hr vs. ALDH2*1/*2, 0.09±0.01 g/L/hr [P<0.05]). Moreover, the comparison of BAC and BrAC by Bland-Altman plot showed good agreement, suggesting that the measurement of BrAC can be a good alternative for the determination of BAC, particularly in the post-absorption phase. These results provide fundamental information about the pharmacokinetics of alcohol and the determination of BAC in forensics.
참고문헌 (25)
- Nutt DJ, "Drug harms in the UK: a multicriteria decision analysis", Lancet, 376, pp.1558~1565 (2010)
- Kelly AT, "An overview of alcohol testing and interpretation in the 21st century", J Pharm Pract, 25, pp.30~36 (2012)
- Jones AW., "Evidence-based survey of the elimination rates of ethanol from blood with applications in forensic casework", Forensic Sci Int, 200, pp.1~20 (2010)
- Song BJ, "Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications", J Proteomics, 74, pp.2691~2702 (2011)
- Higuchi S, "Alcohol and aldehyde dehydrogenase genotypes and drinking behavior in Japanese", Alcohol Clin Exp Res, 20, pp.493~497 (1996)
- Chen YC, "Polymorphism of ethanol-metabolism genes and alcoholism: correlation of allelic variations with the pharmacokinetic and pharmacodynamic consequences", Chem Biol Interact, 178, pp.2~7 (2009)
- Liu J, "Haplotype-based study of the association of alcohol-metabolizing genes with alcohol dependence in four independent populations", Alcohol Clin Exp Res, 35, pp.304~316 (2011)
- Farres J, "Effects of changing glutamate 487 to lysine in rat and human liver mitochondrial aldehyde dehydrogenase. A model to study human (Oriental type) class 2 aldehyde dehydrogenase", J Biol Chem, 269, pp.13854~13860 (1994)
- Zhou J, "Basis for half-of-the-site reactivity and the dominance of the K487 oriental subunit over the E487subunit in heterotetrameric human liver mitochondrial aldehyde dehydrogenase", Biochemistry, 39, pp.12019~12024 (2000)
- Higuchi S, "Aldehyde dehydrogenase genotypes in Japanese alcoholics", Lancet, 343, pp.741~742 (1994)
- Chen CC, "Interaction between the functional polymorphisms of the alcohol-metabolism genes in protection against alcoholism", Am J Hum Genet, 65, pp.795~807 (1999)
- Wright NR, "The influence of habitual alcohol intake on breath-alcohol concentrations following prolonged drinking", Alcohol Alcohol, 33, pp.495~501 (1998)
- Jones AW, "Comparison of ethanol concentrations in venous blood and end-expired breath during a controlled drinking study", Forensic Sci Int, 132, pp.18~25 (2003)
- Edenberg HJ., "The genetics of alcohol metabolism: role of alcohol dehydrogenase and aldehyde dehydrogenase variants", Alcohol Res Health, 30, pp.5~13 (2007)
- Zakhari S., "Overview: how is alcohol metabolized by the body?", Alcohol Res Health, 29, pp.245~254 (2006)
- Lieber CS., "Cytochrome P-4502E1: its physiological and pathological role", Physiol Rev, 77, pp.517~544 (1997)
- Lieber CS., "The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role", Drug Metab Rev, 36, pp.511~529 (2004)
- Niederhut MS, "Three-dimensional structures of the three human class I alcohol dehydrogenases", Protein Sci, 10, pp.697~706 (2001)
- Stone CL, "Amino acid substitutions at position 47 of human beta 1 beta 1 and beta 2 beta 2 alcohol dehydrogenases affect hydride transfer and coenzyme dissociation rate constants", J Biol Chem, 268, pp.892~899 (1993)
- Charlier HA Jr, "Kinetic cooperativity of human liver alcohol dehydrogenase gamma(2)", J Biol Chem, 275, pp.11569~11575 (2000)
- Lee SL, "Functionality of allelic variations in human alcohol dehydrogenase gene family: assessment of a functional window for protection against alcoholism", Pharmacogenetics, 14, pp.725~732 (2004)
- Larson HN, "Structural and functional consequences of coenzyme binding to the inactive asian variant of mitochondrial aldehyde dehydrogenase: roles of residues 475 and 487", J Biol Chem, 282, pp.12940~12950 (2007)
- Chen YC, "Alcohol metabolism and cardiovascular response in an alcoholic patient homozygous for the ALDH2*2 variant gene allele", Alcohol Clin Exp Res, 23, pp.1853~1860 (1999)
- Peng GS, "Pharmacokinetic and pharmacodynamic basis for partial protection against alcoholism in Asians, heterozygous for the variant ALDH2*2 gene allele", Pharmacogenet Genomics, 17, pp.845~855 (2007)
- Jones AW, "Concentration-time profiles of ethanol in arterial and venous blood and end-expired breath during and after intravenous infusion", J Forensic Sci, 42, pp.1088~1094 (1997)